COMPANY PROFILE

Stars Tech

Explore full profile

Developed an eco-friendly snow removal agent using starfish extract

Seoul, South KoreaFounded 2017Biotech & Life Sciences

Valuation $50–100M Last recorded · 2024

Headcount <100 Current team size

Total funding $10–50M Disclosed equity funding

Unlock exact values

About Stars Tech

Stars Tech is a chemical manufacturing company that leverages starfish, a form of marine bio-waste, to develop environmentally friendly products. The company was founded in 2017 with the mission to address environmental problems.

Their flagship product is ECO-ST, a de-icing agent made from starfish extract. This product is positioned as a sustainable alternative to conventional de-icers, which are known to cause environmental damage. ECO-ST is designed to minimize damage to infrastructure such as roads, bridges, and vehicles. The primary market for this product likely includes government bodies and private entities responsible for winter road maintenance.

In addition to their de-icing solution, Stars Tech has ventured into the cosmetics industry with PENELLAGEN, a collagen-based skincare ingredient. This product, also derived from starfish, is marketed as a high-performance ingredient that can penetrate the dermal layer of the skin. The company also produces fertilizers using starfish-extracted marine amino acids.

MoreLess Source: Dealroom company data

At a glance

Status: Operational
Founded: 2017
Headquarters: Seoul, South Korea
Employees: 23
Open positions: None listed
Dealroom signal: 84.4/100
Industry: Health
Sub-industry: BioTechnology
Sector: Biotech & Life Sciences, Biotechnology, Biotech and Pharma, Hard Tech, DT and LS, science-based
Business model: Manufacturing
Client focus: b2b
Links: Website LinkedIn

Knowledge graph

Founder mafia, market maps, research and news connected to this company by Dealroom

Funding history

2 recorded events

Company financing events and reported valuations.

Deal type	Date	Amount	Valuation	Investors	Source
SERIES C✓Equity / VC	May 2024	$13M	$50M	Kiwoom Investment · KB Investment · BNK Venture Investment · POSCO Technology Investment	↗
SERIES B✓Equity / VC	Apr 2021	$0	—	NH Investment & Securities	—

Showing the latest 2 of 2 recorded eventsBook a demo for the full funding history →

Growth signals

Stars Tech website traffic

Latest recorded traffic for Stars Tech is 2.7K monthly website visits, down 10% over the last three months. Stars Tech's team grew 21.1% over the past year.

Latest monthly visits2.7K 3-month web change-10% 1-year team growth+21.1%

Monthly website visitsDec 2020–Jul 2026

Explore monthly traffic historyTrack growth over time and compare with peersBook a demo

Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Company	Headquarters	Status	Employees	Total funding	Valuation
MHMontai HealthAI-powered small molecule platform for developing therapies to treat chronic diseases using a vast collection of human-safe molecules	Cambridge, United States	Operational	57	$50M	$200M
RERedDressAdvanced biologic wound care solutions revolutionizing chronic wound treatment with natural healing processes	Ponte Vedra Beach, United States	Operational
SBSenda BiosciencesSenda Biosciences \| Pioneering Intersystems Biology	Cambridge, United States	Acquired
SESentryHealthA chronic disease management company, offers services for health care professionals, employers, consulting services and onsite health	Louisville, United States	Acquired
TRTRICASTPharmacy data analytics company utilizing industry expertise and powerful software tools to empower our clients	Milwaukee, United States	Operational
MGMedical Knowledge GroupCompany specializing in medical communications, health care consulting, and data analytics	New York City, United States	Acquired
ANAmygdala NeuroscienceFree online portal to create group projects and media item related to neuroscience	Palo Alto, United States	Operational
ABAIKO BiotechnologyTherapeutic candidates for the treatment of pain, addiction, and side effects associated with opioid usage	Portland, United States	Operational